EMEA-000049-PIP01-07-M03

Key facts

Invented name
Plavix
Active substance
clopidogrel
Therapeutic area
Cardiovascular diseases
Decision number
P/233/2010
PIP number
EMEA-000049-PIP01-07-M03
Pharmaceutical form(s)
  • Oral formulation
  • Film-coated tablet
Condition(s) / indication(s)
Prevention of thromboembolic events
Route(s) of administration
Oral use
Contact for public enquiries
Sanofi Pharma Bristol-Myers Squibb SNC
sylvie.gabriel@sanofi-aventis.com
France
Phone: +33 153774152
Fax: +33 153774133
Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-000049-PIP01-07-M03
Compliance opinion date
10/12/2010
Compliance outcome
positive

Decision

How useful was this page?

Add your rating